2.79
price down icon0.71%   -0.02
after-market Handel nachbörslich: 2.85 0.06 +2.15%
loading
Schlusskurs vom Vortag:
$2.81
Offen:
$2.848
24-Stunden-Volumen:
14,687
Relative Volume:
0.81
Marktkapitalisierung:
$28.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-0.1418
EPS:
-19.67
Netto-Cashflow:
$-47.63M
1W Leistung:
-2.11%
1M Leistung:
+2.95%
6M Leistung:
-21.30%
1J Leistung:
-40.06%
1-Tages-Spanne:
Value
$2.78
$2.848
1-Wochen-Bereich:
Value
$2.6804
$3.28
52-Wochen-Spanne:
Value
$2.30
$4.67

Polypid Ltd Stock (PYPD) Company Profile

Name
Firmenname
Polypid Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
61
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-13
Name
Neueste SEC-Einreichungen
Name
PYPD's Discussions on Twitter

Vergleichen Sie PYPD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PYPD
Polypid Ltd
2.79 29.04M 0 -23.87M -47.63M -19.67
Biotechnology icon
ONC
Beigene Ltd Adr
238.76 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.03 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.2548 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
596.85 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
72.69 5.92B 0 -153.72M -103.81M -2.00

Polypid Ltd Stock (PYPD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-28 Eingeleitet Rodman & Renshaw Buy
2021-09-14 Eingeleitet JMP Securities Mkt Outperform
2021-07-30 Eingeleitet Cantor Fitzgerald Overweight
2020-11-24 Hochstufung Raymond James Outperform → Strong Buy
2020-08-10 Eingeleitet Alliance Global Partners Buy
2020-07-21 Eingeleitet BMO Capital Markets Outperform
2020-07-21 Eingeleitet Barclays Overweight
2020-07-21 Eingeleitet Raymond James Outperform
Alle ansehen

Polypid Ltd Aktie (PYPD) Neueste Nachrichten

pulisher
May 21, 2025

PolyPid chairman to step down at June shareholder meeting By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

PolyPid chairman to step down at June shareholder meeting - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

PolyPid Announces Leadership Changes Ahead of June 2025 Shareholder Meeting - TipRanks

May 21, 2025
pulisher
May 20, 2025

PolyPid Opens Virtual Access to Investors: Key Presentation and 1-on-1 Meetings at Lytham Conference - Stock Titan

May 20, 2025
pulisher
May 20, 2025

PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 - GlobeNewswire

May 20, 2025
pulisher
May 19, 2025

Head to Head Survey: PolyPid (NASDAQ:PYPD) & Lombard Medical (OTCMKTS:EVARF) - Defense World

May 19, 2025
pulisher
May 17, 2025

Tenon Medical (NASDAQ:TNON) vs. PolyPid (NASDAQ:PYPD) Critical Comparison - Defense World

May 17, 2025
pulisher
May 15, 2025

PolyPid Ltd. Earnings Call: Progress and Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

PolyPid Ltd. (NASDAQ:PYPD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

PolyPid Ltd. Reports Q1 2025 Results and Trial Progress - TipRanks

May 15, 2025
pulisher
May 14, 2025

Polypid Q1 Net Income USD -8.3 Million - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

PolyPid (PYPD) Prepares for Transformational 2025 with Promising - GuruFocus

May 14, 2025
pulisher
May 14, 2025

PolyPid Completes Enrollment in Phase 3 Trial of D-PLEX100 - TipRanks

May 14, 2025
pulisher
May 14, 2025

PolyPid Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Transcript : PolyPid Ltd., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

PolyPid (PYPD) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 01, 2025

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Update - Defense World

May 01, 2025
pulisher
Apr 29, 2025

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025 - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

PolyPid Q1 2025 Earnings Preview: Surgical Outcomes Biopharma Reports May 14 - Stock Titan

Apr 29, 2025
pulisher
Apr 23, 2025

Reviewing Baxter International (NYSE:BAX) and PolyPid (NASDAQ:PYPD) - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

PolyPid to Participate in The Citizens Life Sciences Conference - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

PolyPid to Reveal Next-Gen Surgical Innovation Pipeline at Elite Citizens Life Sciences Conference - Stock Titan

Apr 22, 2025
pulisher
Apr 19, 2025

Short Interest in PolyPid Ltd. (NASDAQ:PYPD) Declines By 25.9% - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

What is HC Wainwright’s Estimate for PolyPid Q1 Earnings? - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

What is HC Wainwright’s Forecast for PolyPid Q1 Earnings? - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

H.C. Wainwright maintains Buy on PolyPid stock with $11 target - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

PolyPid’s (PYPD) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

H.C. Wainwright maintains Buy on PolyPid stock with $11 target By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 07, 2025

PolyPid stock touches 52-week low at $2.32 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

PolyPid stock touches 52-week low at $2.32 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 03, 2025

Surgical Site Infections Clinical and Non-Clinical Studies, - openPR.com

Apr 03, 2025
pulisher
Mar 24, 2025

Barclays Reaffirms Their Hold Rating on PolyPid (PYPD) - The Globe and Mail

Mar 24, 2025
pulisher
Mar 23, 2025

Comparing Beta Bionics (NASDAQ:BBNX) and PolyPid (NASDAQ:PYPD) - Defense World

Mar 23, 2025
pulisher
Mar 11, 2025

PolyPid Completes Enrollment in Phase 3 Trial for Surgical Infection Prevention - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

PolyPid Announces Successful Completion of Enrollment in - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

PolyPid Announces Successful Completion Of Enrollment In Phase 3 Shield II Trial Of D-Plex100 For The Prevention Of Abdominal Colorectal Surgical Site Infections - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - Yahoo

Mar 11, 2025
pulisher
Mar 10, 2025

Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

PolyPid (NASDAQ:PYPD) Stock Price Up 0.7% – Should You Buy? - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

PolyPid to Participate in the 37th Annual ROTH Conference - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

PolyPid Fireside Chat at ROTH Conference: What New Surgical Innovations Will Management Reveal? - StockTitan

Mar 03, 2025
pulisher
Feb 27, 2025

Polypid Ltd to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Finanzdaten der Polypid Ltd-Aktie (PYPD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$581.44
price down icon 0.60%
$1.39
price up icon 6.92%
$32.50
price down icon 0.28%
$289.00
price down icon 1.22%
$4.2299
price up icon 5.48%
$72.69
price down icon 1.89%
Kapitalisierung:     |  Volumen (24h):